Newsroom

Inner Cosmos Appoints John Freund to Board of Directors and Greg Schulte as Advisory CTO to Advance Psychiatric BCI for Depression

Inner Cosmos Inner Cosmos, a neurotechnology company pioneering psychiatric treatment with a

Interim 36-Month Outcomes from Inner Cosmos’ Psychiatric Neurostimulation Study in Treatment-Resistant Depression